PreTAB Tablet
Virtus Pharmaceuticals PreTAB Tablet supports joint and bone health with a comprehensive blend of vitamins (A, C, D, E, B-complex) and minerals (Calcium, Iron, Iodine, Zinc, Folic Acid). Ideal for individuals seeking daily nutritional support for skeletal well-being.
About This Product
PreTAB Tablet by Virtus Pharmaceuticals is a joint & bone supplement containing 14 active ingredients. It has earned an N+ Score of 75/100 (Grade C+).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Thiamine, Riboflavin, Niacin and 10 more.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +13 ingredient(s) at clinical dose levels
- +Rich formula with 14 active ingredients
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (14 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Thiamine | 3.000 mg | Optimal |
| Riboflavin | 3.000 mg | Optimal |
| Niacin | 20.000 mg | Optimal |
| Vitamin B6 | 3.000 mg | Optimal |
| Vitamin B12 | 8.000 mcg | Optimal |
| Vitamin A | 4000.000 IU | High |
| Vitamin C | 120.000 mg | Adequate |
| Vitamin D | 400.000 IU | Adequate |
| Vitamin E | 30.000 IU | Optimal |
| Calcium | 200.000 mg | Adequate |
| Iron | 29.000 mg | Optimal |
| Iodine | 150.000 mcg | Optimal |
| Zinc | 15.000 mg | Optimal |
| Folic Acid | 1.000 mg | Under |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
